Peter Pushko Selected Research

DNA (Deoxyribonucleic Acid)

12/2017	Plasmid DNA launches live-attenuated Japanese encephalitis virus and elicits virus-neutralizing antibodies in BALB/c mice.
2/2013	Novel vaccine against Venezuelan equine encephalitis combines advantages of DNA immunization and a live attenuated vaccine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter Pushko Research Topics

Disease

17	Human Influenza (Influenza) 01/2022 - 12/2005
10	Influenza in Birds (Avian Flu) 01/2019 - 12/2005
8	Infections 07/2021 - 05/2002
6	Venezuelan Equine Encephalomyelitis 01/2020 - 12/2003
2	Lassa Fever (Fever, Lassa) 01/2016 - 10/2007
1	Inflammation (Inflammations) 03/2020
1	Viremia 01/2020
1	Virus Diseases (Viral Diseases) 01/2017
1	Fever (Fevers) 11/2012
1	Yellow Fever 11/2012
1	Neoplasms (Cancer) 12/2003

Drug/Important Bio-Agent (IBA)

25	VaccinesIBA 01/2022 - 05/2002
11	Hemagglutinins (Hemagglutinin)IBA 01/2022 - 12/2005
10	Proteins (Proteins, Gene)FDA Link 03/2016 - 12/2005
8	Neuraminidase (Sialidase)IBA 01/2017 - 12/2005
3	AntigensIBA 01/2022 - 12/2003
3	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2019 - 05/2007
3	AntibodiesIBA 07/2010 - 12/2005
2	Neutralizing AntibodiesIBA 01/2020 - 04/2015
2	Glycoproteins (Glycoprotein)IBA 01/2020 - 10/2007
2	RNA (Ribonucleic Acid)IBA 01/2020 - 01/2018
2	DNA (Deoxyribonucleic Acid)IBA 12/2017 - 02/2013
2	Attenuated VaccinesIBA 12/2017 - 02/2013
1	CytokinesIBA 03/2020
1	AerosolsIBA 01/2020
1	gag Gene Products (gag Protein)IBA 01/2017
1	Viral HemagglutininsIBA 03/2016
1	Amino Acids FDA Link 01/2016
1	Combined VaccinesIBA 01/2013
1	Synthetic Vaccines (Recombinant Vaccines)IBA 12/2005
1	Green Fluorescent ProteinsIBA 05/2004
1	AutoantigensIBA 12/2003

Therapy/Procedure

1	Therapeutics 08/2011
1	Immunotherapy 12/2003